Sai Life Sciences Sustainability Report 2022

18 ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................... Our growth Strong pool of scientific talent Awards and recognition R&D 1200 2200 employees Quality 300 Manufacturing 650 100+ clinical stage programs served; 28 active commercial programs & 9 in Phase III USA, EU, Japan > 95% of products manufactured serve these highly regulated markets USFDA, PMDA 100% successful track record of regulatory inspections across our R&D and manufacturing facilities 35+ programs advanced from IND to phase I, II or III Member of > 200 active customers of innovator companies Sai Life Sciences’ API manufacturing unit receives ‘CII Excellent Energy Unit’ award Sai Life Sciences’ wins GSK Environmental Sustainability Supplier award 2021 in the ‘Primary Manufacturing’ category .

RkJQdWJsaXNoZXIy MTIwMDc4NQ==